Carbidopa Tablet
FDA Label NDC 70771-1355

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Carbidopa (NDC 70771-1355). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package Label.Principal Display Panel

NDC 70771-1355-1

Carbidopa Tablets

Rx only

100 Tablets

 

Carbidopa Tablets, 25 mg (F5e78c6b F2eb 4635 Bc10 1d4b96513117 02)

Carbidopa Tablets, 25 mg (F5e78c6b F2eb 4635 Bc10 1d4b96513117 02)

* Please review the disclaimer below.